Skip to main content
Article
Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells
Cancer Letters (2015)
  • Inna Zubrilov, Tel Aviv University
  • Orit Sagi-Assif, Tel Aviv University
  • Sivan Izraely, Tel Aviv University
  • Tsipi Meshel, Tel Aviv University
  • Shlomit Ben-Menahem, Tel Aviv University
  • Ravit Ginat, Tel Aviv University
  • Metsada Pasmanik-Chor, Tel Aviv University
  • Clara Nahmias, Institut Gustave Roussy
  • Pierre-Olivier Couraud, Paris Descartes University
  • Pierre-Olivier Couraud, French Institute of Health and Medical Research
  • Pierre-Olivier Couraud, Centre national de la recherche scientifique
  • Dave S.B. Hoon
  • Isaac P. Witz, Tel Aviv University
Publication Date
May 1, 2015
DOI
10.1016/j.canlet.2015.02.041
Citation Information
Inna Zubrilov, Orit Sagi-Assif, Sivan Izraely, Tsipi Meshel, et al.. "Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells" Cancer Letters Vol. 361 Iss. 1 (2015) p. 86 - 96
Available at: http://works.bepress.com/dave-hoon/75/